Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs

This site requires Adobe Flash Player on your browser.
Please install Adobe Flash Player from here.

Uploaded by: Ani
on Wed, 12 May 2021 09:53:48 IST
 

Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs Show more

Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs  Show less

Click here for Embed Code
  Embed: Hide

Comments